Please assess the completion status of the following clinical trial:

Trial Title: Urokinase Therapy in Patients With Diabetic Foot Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diabetic patients with angiopathic or angioneuropathic diabetic foot syndrome and criticial limb ischemia~* No surgical or interventional treatment option~* No healing tendency of ulcerations despite of antibiosis and wound debridement after two-week treatment~* Fibrinogen \> 4.0 g/l~* No previous major amputation~Exclusion Criteria:~* Prior treatment of the current ulceration with urokinase~* Need for dialysis and/or creatinine-clearance \< 20ml/min~* INR \> 1,5 at screening~* Any kind of cerebral event within 3 months prior inclusion~* Proliferative retinopathy~* Uncontrolled hypertension~* Hemorraghic diathesis~* Gastrointestinal bleeding~* Pregnancy~* No compliance and/or participation in another trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A: Standard therapy (Type: OTHER): None
- B: Urokinase (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).